Daina Selga
About
In The Last Decade
Daina Selga
18 papers receiving 449 citations
Peers
Comparison fields: 5 of 39
- Pulmonary and Respiratory Medicine 386
- Genetics 136
- Nephrology 134
- Rheumatology 134
- Immunology 106
Countries citing papers authored by Daina Selga
This map shows the geographic impact of Daina Selga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daina Selga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daina Selga more than expected).
Fields of papers citing papers by Daina Selga
This network shows the impact of papers produced by Daina Selga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daina Selga. The network helps show where Daina Selga may publish in the future.
Co-authorship network of co-authors of Daina Selga
This figure shows the co-authorship network connecting the top 25 collaborators of Daina Selga. A scholar is included among the top collaborators of Daina Selga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daina Selga. Daina Selga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 11 | |
| 3 | 17 | |
| 4 | 61 | |
| 5 | Phase 2 randomised trial of oral C5A receptor antagonist CCX168 in ANCA-associated renal vasculitis | 4 |
| 6 | 12 | |
| 7 | 70 | |
| 8 | 2 | |
| 9 | 15 | |
| 10 | [The HUS epidemic in the summer of 2011 was severe. German and Swedish experiences of the EHEC outbreak]. | 5 |
| 11 | 7 | |
| 12 | Capture ELISA for PR3-ANCA is superior to detect and predict relapses of systemic vasculitis compared with direct ELISA | 1 |
| 13 | 53 | |
| 14 | 33 | |
| 15 | 19 | |
| 16 | 41 | |
| 17 | 20 | |
| 18 | 78 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.